Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Cadila Healthcare Q2 net profit up 32 percent at Rs 503 croreCadila Healthcare Q2 net profit up 32 percent at Rs 503 crore
    Apollo Hospitals Q2 net dips 23 percent to Rs 71 croreApollo Hospitals Q2 net dips 23 percent to Rs 71 crore
    NPPA invites representation and suggestion on Coronary StentsNPPA invites representation and suggestion on Coronary Stents
    CureFit to expand to Delhi-NCR, invest Rs 25 croreCureFit to expand to Delhi-NCR, invest Rs 25 crore
    Abbott India Q2 profit rises 83 percent to Rs 137.52 croreAbbott India Q2 profit rises 83 percent to Rs 137.52 crore
    Morepen Labs reports 24 percent jump in its Q2 net profitMorepen Labs reports 24 percent jump in its Q2 net profit
    Pfizer Q2 net dips 12 percent at Rs 111.15 crorePfizer Q2 net dips 12 percent at Rs 111.15 crore
    Novartis posts eye drug data amid play for EyleaNovartis posts eye drug data amid play for Eylea's turf
    Suven Life Sciences Q2 net up 20 percent to Rs 32 croreSuven Life Sciences Q2 net up 20 percent to Rs 32 crore
    CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancerCDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer
    OmniActive Health eyes more takeovers, to invest Rs 150 croreOmniActive Health eyes more takeovers, to invest Rs 150 crore
    Roche MS drug Ocrevus wins European panel backingRoche MS drug Ocrevus wins European panel backing
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok